Biotron Limited (ASX:BIT) Completes Safety Study for HBV Drug
Biotron Limited (ASX:BIT) completes safety study for its HBV drug, advancing to efficacy testing in animal models.
Category: ASX-BIT
Biotron Limited
Latest News
Brightstar Resources (ASX:BTR) Reports Significant Results from Sandstone Hub Drilling
Kip McGrath Education Centres (ASX:KME) Provides FY25 Trading Update and Announces Exit from USA Business
GBM Resources Limited (ASX:GBZ) Announces $13 Million Placement and Board Restructure
Eureka Group Holdings Limited (ASX:EGH) Appoints Simon Owen as Managing Director
Biotron Limited (ASX:BIT) Completes Safety Study for HBV Drug
Dexus (ASX:DXS) Announces Portfolio Valuation Increase and Estimated Distribution
Maggie Beer Holdings (ASX:MBH) Completes Sale of Paris Creek Farms
PYC Therapeutics (ASX:PYC) Aligns with FDA on Registrational Trial Design for RP11 Treatment
Sunshine Metals (ASX:SHN) Completes Sybil Project Acquisition
Downer EDI Limited (ASX:DOW) Successfully Completes $1 Billion Refinancing
The Hub of Australian Finance News